Joseph Edelman – ALDX history
- Issuer:
- ALDEYRA THERAPEUTICS INC
- Quarters tracked:
- 40 (Q2 2016 → Q1 2026)
- Current shares:
- 0
- Current value:
- $0
- Peak shares:
- 11,350,085 (Q3 2022)
- Overall change:
- -100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | SOLD | — | — | -4,185,632 | -100% |
| Q4 2025 | 4,185,632 | $21.68M | $5.18 | -1,036,679 | -20% |
| Q3 2025 | 5,222,311 | $27.26M | $5.22 | +1,170,680 | +29% |
| Q2 2025 | 4,051,631 | $15.52M | $3.83 | -5,224,220 | -56% |
| Q1 2025 | 9,275,851 | $53.34M | $5.75 | 0 | 0% |
| Q4 2024 | 9,275,851 | $46.29M | $4.99 | 0 | 0% |
| Q3 2024 | 9,275,851 | $50.00M | $5.39 | 0 | 0% |
| Q2 2024 | 9,275,851 | $30.70M | $3.31 | +682,265 | +8% |
| Q1 2024 | 8,593,586 | $28.10M | $3.27 | 0 | 0% |
| Q4 2023 | 8,593,586 | $30.16M | $3.51 | -2,756,499 | -24% |
| Q3 2023 | 11,350,085 | $75.82M | $6.68 | 0 | 0% |
| Q2 2023 | 11,350,085 | $95.23M | $8.39 | 0 | 0% |
| Q1 2023 | 11,350,085 | $112.71M | $9.93 | 0 | 0% |
| Q4 2022 | 11,350,085 | $79.00M | $6.96 | 0 | 0% |
| Q3 2022 | 11,350,085 | $60.61M | $5.34 | +1,446,206 | +15% |
| Q2 2022 | 9,903,879 | $39.52M | $3.99 | 0 | 0% |
| Q1 2022 | 9,903,879 | $44.02M | $4.45 | 0 | 0% |
| Q4 2021 | 9,903,879 | $39.62M | $4.00 | 0 | 0% |
| Q3 2021 | 9,903,879 | $86.96M | $8.78 | 0 | 0% |
| Q2 2021 | 9,903,879 | $112.21M | $11.33 | +1,200,000 | +14% |
| Q1 2021 | 8,703,879 | $103.40M | $11.88 | +2,418,421 | +38% |
| Q4 2020 | 6,285,458 | $43.12M | $6.86 | 0 | 0% |
| Q3 2020 | 6,285,458 | $46.58M | $7.41 | +3,200,000 | +104% |
| Q2 2020 | 3,085,458 | $12.87M | $4.17 | 0 | 0% |
| Q1 2020 | 3,085,458 | $7.62M | $2.47 | 0 | 0% |
| Q4 2019 | 3,085,458 | $17.93M | $5.81 | 0 | 0% |
| Q3 2019 | 3,085,458 | $16.26M | $5.27 | 0 | 0% |
| Q2 2019 | 3,085,458 | $18.51M | $6.00 | 0 | 0% |
| Q1 2019 | 3,085,458 | $27.86M | $9.03 | 0 | 0% |
| Q4 2018 | 3,085,458 | $24.68M | $8.00 | 0 | 0% |
| Q3 2018 | 3,085,458 | $42.58M | $13.80 | 0 | 0% |
| Q2 2018 | 3,085,458 | $24.53M | $7.95 | 0 | 0% |
| Q1 2018 | 3,085,458 | $23.14M | $7.50 | 0 | 0% |
| Q4 2017 | 3,085,458 | $20.98M | $6.80 | 0 | 0% |
| Q3 2017 | 3,085,458 | $22.21M | $7.20 | +200,000 | +7% |
| Q2 2017 | 2,885,458 | $13.42M | $4.65 | 0 | 0% |
| Q1 2017 | 2,885,458 | $12.90M | $4.47 | +945,000 | +49% |
| Q4 2016 | 1,940,458 | $10.38M | $5.35 | 0 | 0% |
| Q3 2016 | 1,940,458 | $15.17M | $7.82 | 0 | 0% |
| Q2 2016 | 1,940,458 | $11.04M | $5.69 | — | NEW |